Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
Venoocclusive disease (VOD) is due to hepatic sinusoidal lining injury leading to portal hypertension; its incidence after liver transplantation is about 2%. When severe, it does not respond to medical therapy and has a high mortality; retransplantation is the only therapeutic option. However, there are no detailed data regarding the use of transjugular intrahepatic portosystemic shunt for VOD after liver transplantation. We describe two patients who developed severe VOD after liver transplantation, failed defibrotide therapy, and were treated by transjugular intrahepatic portosystemic shunt (TIPS). The portal hypertension resolved completely and one had full histological recovery. We believe that TIPS should be attempted as it may resolve progressive portal hypertension and the hepatic congestion, while allowing the clinician time for listing for further liver transplantation if the patient fails to respond.
Senzolo
Marco
M
Liver Transplantation and Hepatobiliary Unit, Royal Free Hospital, London, United Kingdom.
Patch
David
D
Cholongitas
Evangelos
E
Triantos
Christos
C
Marelli
Laura
L
Stigliano
Rosa
R
Dhillon
Amar
A
Burroughs
Andrew
A
D005260:Female; D006504:Hepatic Veno-Occlusive Disease / Q000601:surgery*; D006801:Humans; D016031:Liver Transplantation / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D016896:Treatment Outcome